Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases.

[1]  G. Caimi,et al.  Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey. , 2021, Clinical hemorheology and microcirculation.

[2]  G. Caimi,et al.  Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders. , 2021, Microvascular research.

[3]  G. Preta.  New Insights Into Targeting Membrane Lipids for Cancer Therapy , 2020, Frontiers in Cell and Developmental Biology.

[4]  F. Goñi,et al.  A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis , 2020, Nature Communications.

[5]  Takao Shimizu,et al.  Roles of polyunsaturated fatty acids, from mediators to membranes , 2020, Journal of Lipid Research.

[6]  G. Caimi,et al.  Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype. , 2020, Clinical hemorheology and microcirculation.

[7]  A. Doctor,et al.  Red Blood Cell Dysfunction in Critical Illness. , 2020, Critical care clinics.

[8]  G. Caimi,et al.  Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders. , 2019, Panminerva Medica (Testo stampato).

[9]  M. Faivre,et al.  Impact of surface-area-to-volume ratio, internal viscosity and membrane viscoelasticity on red blood cell deformability measured in isotonic condition , 2019, Scientific Reports.

[10]  B. Paul,et al.  Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma , 2019, Journal of cancer metastasis and treatment.

[11]  L. Molday,et al.  Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells , 2019, The Journal of Biological Chemistry.

[12]  D. Voelker,et al.  Interaction of two antitumor peptides with membrane lipids – Influence of phosphatidylserine and cholesterol on specificity for melanoma cells , 2019, PloS one.

[13]  V. Novakovic,et al.  Phosphatidylserine-exposing cells contribute to the hypercoagulable state in patients with multiple myeloma. , 2018, International journal of oncology.

[14]  Peipei Xu,et al.  Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[15]  G. Caimi,et al.  Erythrocyte deformability and hemorheological profile in multiple myeloma. , 2017, Clinical hemorheology and microcirculation.

[16]  G. Caimi,et al.  Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS). , 2017, Clinical hemorheology and microcirculation.

[17]  G. Caimi,et al.  Red blood cell deformability in multiple myeloma1. , 2018, Clinical hemorheology and microcirculation.

[18]  Jun Xia,et al.  Evaluation of pretreatment red cell distribution width in patients with multiple myeloma. , 2017, Cancer biomarkers : section A of Disease markers.

[19]  Nobuto Arashiki,et al.  Maintenance and regulation of asymmetric phospholipid distribution in human erythrocyte membranes: implications for erythrocyte functions , 2017, Current opinion in hematology.

[20]  A. Zannettino,et al.  The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine‐expressing myeloma cells , 2017, British journal of haematology.

[21]  Chenyang Lu,et al.  Prognostic Value of Elevated Red Blood Cell Distribution Width in Chinese Patients with Multiple Myeloma , 2017, Annals of clinical and laboratory science.

[22]  S. Yedgar,et al.  Biophysical and Biochemical Markers of Red Blood Cell Fragility , 2017, Transfusion Medicine and Hemotherapy.

[23]  S. Hasić,et al.  Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients , 2016, Medical archives.

[24]  S. Miyano,et al.  ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia , 2016, Haematologica.

[25]  S. Rajkumar.  Evolving diagnostic criteria for multiple myeloma. , 2015, Hematology. American Society of Hematology. Education Program.

[26]  M. Angelopoulou,et al.  Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myeloma undergoing autologous stem cell transplantation. , 2015, Hematology/oncology and stem cell therapy.

[27]  J. Castillo,et al.  Plasma fatty acid profile in multiple myeloma patients. , 2015, Leukemia research.

[28]  J. Castillo,et al.  Erythrocyte membrane fatty acids in multiple myeloma patients. , 2014, Leukemia research.

[29]  Hong Liu,et al.  Hepcidin and GDF15 in anemia of multiple myeloma , 2014, International Journal of Hematology.

[30]  G. Nicolson,et al.  The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years. , 2014, Biochimica et biophysica acta.

[31]  Hyoeun Shim,et al.  Elevated Red Blood Cell Distribution Width as a Simple Prognostic Factor in Patients with Symptomatic Multiple Myeloma , 2014, BioMed research international.

[32]  Juan Li,et al.  Detection of erythrocytes in patients with Waldenstrom macroglobulinemia using atomic force microscopy. , 2014, Acta biochimica et biophysica Sinica.

[33]  K. Konstantopoulos,et al.  The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[34]  I. Cózar-Castellano,et al.  Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation , 2012, PloS one.

[35]  Shunqing Wang,et al.  Detection of erythrocytes in patients with multiple myeloma using atomic force microscopy. , 2012, Scanning.

[36]  S. Naseem,et al.  Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma. , 2012, Indian Journal of Pathology and Microbiology.

[37]  R. Hájek,et al.  [Prognostic significance of morphology in multiple myeloma]. , 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[38]  Chia-Wei Sun,et al.  Correlation between tissue oxygenation and erythrocytes elasticity , 2011, Journal of biophotonics.

[39]  M. Dimopoulos,et al.  High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents , 2010, European journal of haematology.

[40]  N. Jonjić,et al.  Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma , 2010, Diagnostic pathology.

[41]  P. Rzehak,et al.  Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes , 2008, British Journal of Nutrition.

[42]  Hong Wang,et al.  Increased fatty acid synthase as a potential therapeutic target in multiple myeloma , 2008, Journal of Zhejiang University SCIENCE B.

[43]  P. Cabrales,et al.  Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions. , 2006, American journal of physiology. Heart and circulatory physiology.

[44]  Manabu T. Nakamura,et al.  STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES , 2004 .

[45]  D. Mavrogianni,et al.  Unusual Association between Increased Bone Resorption and Presence of Paroxysmal Nocturnal Hemoglobinuria Phenotype in Multiple Myeloma , 2003, International journal of hematology.

[46]  F. Dammacco,et al.  Recent Advances in Understanding the Pathogenesis of Anemia in Multiple Myeloma , 2003, International journal of hematology.

[47]  K. Konstantopoulos,et al.  Red Cells with Paroxysmal Nocturnal Hemoglobinuria-phenotype in Patients with Acute Leukemia , 2002, Hematology.

[48]  K. Konstantopoulos,et al.  Detection of CD55- and/or CD59-Deficient Red Cell Populations in Patients With Plasma Cell Dyscrasias , 2002, International journal of hematology.

[49]  F. Dammacco,et al.  Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression. , 2001, Blood.

[50]  D. Mavrogianni,et al.  Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders. , 2001, Haematologia.

[51]  D. Mavrogianni,et al.  Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes. , 2001, The hematology journal : the official journal of the European Haematology Association.

[52]  G. Caimi,et al.  Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells , 2000, Diabetologia.

[53]  H H Lipowsky,et al.  Capillary recruitment in response to tissue hypoxia and its dependence on red blood cell deformability. , 1999, American journal of physiology. Heart and circulatory physiology.

[54]  R. Bartl,et al.  Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS. , 1999, Pathologie et biologie.

[55]  Terry L. Smith,et al.  High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma. , 1991, Annals of internal medicine.

[56]  S. Wakil,et al.  Fatty acid synthase, a proficient multifunctional enzyme. , 1989, Biochemistry.

[57]  S. Wakil,et al.  Fatty acid synthesis and its regulation. , 1983, Annual review of biochemistry.